pharmtrace is a German based startup that specializes in providing professional solutions for imaging and radiopharmaceuticals in clinical trials. Established in 2006, pharmtrace is an independent high-quality imaging CRO offering flexible services and a global reach to meet imaging endpoints for clinical trials. The company's services encompass site management activities, central independent image assessment, data transfer and analysis, site qualification, site training, image upload, inventory and queries, read planning, reader training, and status trackers. pharmtrace's proprietary software for independent reads, ERICA, combines regulatory compliance with up-to-date image visualization and analysis tools. The company's experienced team and international medical specialists network ensure the delivery of meaningful data from medical imaging investments. Its clientele includes biotech, academia, globally engaged pharmaceutical companies, and device manufacturers, with a focus on collaborating closely with in-house teams and external providers. Although specific details about the latest investment and investors remain undisclosed, pharmtrace's industry experience and comprehensive imaging solutions position it as a promising player in the field of clinical trials and medical imaging.
There is no investment information
No recent news or press coverage available for pharmtrace.